MyFinsight
Home
Blog
About
Contact
Back
Income Statement
Apimeds Pharmaceuticals US, Inc. (APUS)
Apimeds Pharmaceuticals US, Inc. (APUS)
source: myfinsight.com
Net gain
-$35,059,852
Total other income
(expense)
-$22,874,158
Loss from operations
-$12,185,694
Change in fv of
derivative
-$48,279
Realized gain on sale of
digital assets
$15,100
Trading gains, net
$2,029
Interest income
$7
Unrealized gain (loss)from
changes in fair value of...
-$22,078,601
Interest expense
$859,405
Total operating
expenses
$12,185,694
Foreign currency
gains/(losses), net
-$1,567
General and
administrative expenses
$11,284,550
Research and development
expenses
$901,144
Back